MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Limitations of Curcumin as a Therapeutic Agent in Rotenone Induced Dopaminergic Neurodegeneration: Insights from Drosophila Model of Parkinson’s Disease

    M. Ayajuddin, SC. Yenisetti (Zunheboto, India)

  • Lip movement contribution in speech production of persons with Parkinson’s Disease

    P. Upadhyay, S. Gudwani, K. Sharma, R. Sagar, R. Dhamija, S. Kumaran (New Delhi, India)

  • Liquid Levodopa/Carbidopa – An underutilized, cost effective treatment of advanced Parkinson’s disease in the developing world

    A. Panwar, N. Sawal (Chandigarh, India)

  • Local anesthesia vs general anesthesia in STN-dDBS operation: a clinical comparison of the outcome of patients with advanced Parkinson’s disease

    M. Koivu, J. Resendiz-Nieves, J. Eerola-Rautio, F. Scheperjans, R. Kivisaari, E. Pekkonen (Helsinki, Finland)

  • Local beta band synchronization predicts clinically-selected deep brain stimulation contact in Parkinson’s disease patients

    W. Lipski, HJ. Park, A. Jorge, A. Kent, Y. Pathak, RM. Richardson (Pittsburgh, PA, USA)

  • Local field potential recordings in the human pallidum using externalized directional DBS leads

    L. Johnson, J. Aman, D. Escobar Sanabria, J. Wang, R. Patriat, M. Petrucci, M. Hill, G. Molnar, S. Cooper, L. Schrock, C. Mackinnon, N. Harel, M. Park, J. Vitek (Minneapolis, MN, USA)

  • Long term evolution of ventilatory function in Parkinson’s disease

    G. Baille, C. Chenivesse, T. Perez, D. Devos, L. Defebvre, C. Moreau (Lille, France)

  • Long Term Follow Up Following Multidisciplinary Inpatient Rehabilitation for Functional Movement Disorders

    A. Kompoliti, C. Hebert, J. Behel, G. Pal, R. Kasi (Chicago, IL, USA)

  • Long term outcome of STN-DBS for Parkinson Disease patients using Directional mode setting programs

    K. Kimura, H. Kishida, T. Kawasaki, N. Ueda, F. Tanaka (Yokohama, Japan)

  • Long-term adherence with wearing a multi-sensor watch in the Personalized Parkinson Project

    L. Evers, R. Kapur, T. V.D. Zande, M. Meinders, B. Bloem, W. Marks, JR. (Nijmegen, Netherlands)

  • « Previous Page
  • 1
  • …
  • 115
  • 116
  • 117
  • 118
  • 119
  • …
  • 217
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley